Answers are grounded in this paper and cite their sources.
Background Cognitive involvement in hereditary transthyretin amyloidosis (ATTRv) remains poorly characterized. This study aimed to describe the neuropsychological performance of V122I ( p.Val142Ile ) carriers. Methods Exploratory cross-sectional study involving individuals who were carriers of a pathogenic variant in the transthyretin (TTR) gene. Participants underwent a neuropsychological battery assessing memory, attention, executive functions, and visuospatial abilities. Results A total of 22 individuals were included, all carriers of the V122I variant in the TTR gene, of whom 14 (63.6%) were asymptomatic, and eight (36.4%) were symptomatic. The mean age was 53 years, with 12 (54.5%) male participants and a mean educational level of 8.5 years. Impairment on the Mini-Mental State Examination was observed in 18 (81.8%) participants. Verbal episodic memory was the most affected domain, with scores in the below average to exceptionally low range on delayed recall observed in 13 of 14 (93%) asymptomatic and 7 of 8 (88%) symptomatic individuals. Visuospatial and constructive abilities, as assessed by the Clock Drawing Test, were impaired in 14 of 22 (63.6%) participants, 11 of 14 (79%) asymptomatic and 3 of 8 (38%) symptomatic individuals. Conclusion V122I carriers, including those without overt clinical manifestations, frequently performed below normative expectations on neuropsychological tests, most prominently in verbal episodic memory, with frequent low scores also in attention, visuoconstructive, and executive tasks. These preliminary findings warrant confirmation in larger, controlled studies.
No takes yet. Share an insight, caveat, or question.
Costa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: